What is the role of magnesium [Mg] in the Inactivated Polio Vaccine (IPV)?
Live influenza vaccine is given by which route?
What is the mechanism of action of metyrosine?
What is the typical maintenance dose of Levetiracetam in pediatric patients?
What is the mechanism of action of Iloprost?
Which drug acts primarily as a selective 5HT4 receptor agonist?
Rasburicase is a recombinant form of which enzyme?
Which of the following compounds is most commonly used as an antacid in pharmaceutical formulations?
Which of the following conditions is treated with botulinum toxin?
Advantage of glycopyrrolate over atropine is?
Explanation: ***Stabilizer*** - Magnesium (Mg) is included in IPV formulations primarily to **maintain the integrity and potency** of the viral antigens. - It helps prevent the **degradation of the inactivated poliovirus** particles, ensuring a consistent immune response upon vaccination. *Adjuvant* - Adjuvants are substances that **enhance the immune response** to an antigen, often by creating a depot effect or stimulating immune cells. - While essential in some vaccines, magnesium's role in IPV is not primarily to boost immunogenicity but to protect the antigen itself. *Preservative* - Preservatives are added to multi-dose vaccine vials to **prevent microbial contamination** after the vial has been opened. - Common preservatives include 2-phenoxyethanol or thimerosal (though less frequently used now), which have antimicrobial properties not shared by magnesium. *Antiinfective* - An antiinfective agent's primary function is to **kill or inhibit the growth of infectious microorganisms**. - Magnesium does not possess significant antiinfective properties at the concentrations used in vaccines and is not intended to treat or prevent infections in this context.
Explanation: ***Intranasal*** - The **live attenuated influenza vaccine (LAIV)** is specifically designed for **intranasal administration**, allowing it to mimic natural infection in the respiratory tract. - This route promotes a robust **mucosal immune response**, which is crucial for respiratory pathogens. *Intradermal* - **Intradermal vaccines** are typically administered into the dermis, beneath the epidermis. - While some influenza vaccines (e.g., Fluzone Intradermal) exist, the **live influenza vaccine** is not given via this route. *Subcutaneous* - **Subcutaneous injection** delivers the vaccine into the fatty tissue just under the skin. - While some vaccines are given subcutaneously, the **live attenuated influenza vaccine** is not. *Intramuscular* - Most **inactivated influenza vaccines** are administered intramuscularly, depositing the vaccine into muscle tissue. - The **live attenuated influenza vaccine** is not given via this route as it is designed to replicate in the upper respiratory tract.
Explanation: ***Tyrosine hydroxylase*** - **Metyrosine** acts as a **competitive inhibitor** of **tyrosine hydroxylase**, which is a crucial enzyme in the **catecholamine synthesis pathway**. - By blocking this rate-limiting step, metyrosine reduces the production of **dopamine**, **norepinephrine**, and **epinephrine**. *Phenylethanolamine N-methyltransferase* - This enzyme converts **norepinephrine to epinephrine** and is not the primary target of metyrosine. - While metyrosine indirectly affects downstream products, its direct action is not on this enzyme. *Phenylalanine hydroxylase* - This enzyme converts **phenylalanine to tyrosine** and is associated with conditions like **phenylketonuria**. - It is not involved in the direct synthesis of catecholamines from tyrosine, nor is it the target of metyrosine. *Tyrosinase* - **Tyrosinase** is involved in the synthesis of **melanin**, not catecholamines. - Inhibition of this enzyme would primarily affect pigmentation, which is unrelated to metyrosine's therapeutic use.
Explanation: ***30 - 40 mg/kg/day*** - Levetiracetam is often initiated with a lower dose (e.g., 10-15 mg/kg/day) and **titrated upwards** to achieve seizure control. - The typical maintenance dose for Levetiracetam, especially in pediatric patients, is generally considered to be in the range of **30-40 mg/kg/day** administered in two divided doses. *10 - 20 mg/kg/day* - This range is more typical for the **initial starting dose** of Levetiracetam, rather than the maintenance dose. - While sometimes used as a maintenance dose in specific adult cases or for mild seizure control, it is often considered **sub-therapeutic** for many patients. *20 - 30 mg/kg/day* - This dose range can be an **intermediate dose** during titration, or a maintenance dose for some patients, but it is generally at the lower end of the effective maintenance range. - Many patients require a higher dose to achieve **optimal seizure control** without intolerable side effects. *40 - 50 mg/kg/day* - Doses in this range are often associated with an **increased risk of side effects**, such as somnolence, asthenia, and behavioral changes [1]. - While some patients may require these higher doses under careful supervision, they are generally **above the typical maintenance dose** and should be considered only when lower doses are ineffective.
Explanation: ***Thromboxane receptor antagonist*** - This statement is incorrect. **Iloprost** is an analogue of **prostacyclin (PGI2)**, not a thromboxane receptor antagonist. - It works by mimicking the effects of natural prostacyclin, leading to **vasodilation** and **inhibition of platelet aggregation**. *Thromboxane synthetase antagonist* - **Thromboxane synthetase inhibitors** prevent the production of thromboxane A2, a potent vasoconstrictor and platelet aggregator. - While this is a different mechanism from iloprost, drugs like **dazoxiben** act this way to achieve similar clinical effects of reduced vasoconstriction and platelet aggregation. *PGE 1 analogue* - **PGE1 analogues** (like **alprostadil**) are primarily used to maintain patent ductus arteriosus in neonates or for erectile dysfunction. - While PGE1 also has vasodilatory and antiplatelet effects, **iloprost** specifically mimics **PGI2**. *PGI 2 analogue* - This is the **correct mechanism of action** for **Iloprost**. Iloprost is a stable synthetic analogue of **prostacyclin (PGI2)**. - By activating **prostacyclin receptors**, it causes **vasodilation** (especially in the pulmonary and systemic vasculature) and potent **inhibition of platelet aggregation**.
Explanation: ***Renzapride*** - **Renzapride** is a **selective 5-HT4 receptor agonist** used to stimulate gut motility, particularly in conditions like chronic constipation. - It enhances the release of acetylcholine in the enteric nervous system, promoting **gastrointestinal motility**. - Unlike metoclopramide, renzapride's **primary mechanism** is 5-HT4 receptor agonism. *Loxiglumide* - **Loxiglumide** is an antagonist of the **cholecystokinin-A (CCK-A) receptor**, not the 5-HT4 receptor. - It is used experimentally to inhibit the effects of CCK, such as gallbladder contraction and pancreatic enzyme secretion. *Atractiloside* - **Atractiloside** is a plant toxin that interferes with mitochondrial function by inhibiting the **adenine nucleotide translocase (ANT)**. - It is not a pharmacological agent targeting serotonin receptors, but rather a mitochondrial poison. *Metoclopramide* - **Metoclopramide** primarily acts as a **D2 dopamine receptor antagonist**, which is its main mechanism for prokinetic effects. - While it has **some 5-HT4 agonistic activity**, this is a **secondary mechanism**, and its primary action is dopamine antagonism. - It is also a **5-HT3 antagonist** at higher doses, making it a mixed-mechanism drug rather than a selective 5-HT4 agonist like renzapride.
Explanation: ***Urate Oxidase*** - **Rasburicase** is a recombinant **urate oxidase** enzyme that catalyzes the oxidation of uric acid into allantoin. - This conversion makes uric acid more soluble and easier to excrete, thereby lowering serum uric acid levels, which is crucial in managing or preventing **tumor lysis syndrome** [2]. *Xanthine oxidase* - **Xanthine oxidase** is involved in the catabolism of purines, converting xanthine to uric acid [1]. - **Allopurinol**, a common drug for hyperuricemia, inhibits xanthine oxidase, but rasburicase does not act as an analogue or inhibitor of this enzyme [3], [4]. *IMP dehydrogenase* - **IMP dehydrogenase** is an enzyme involved in the de novo synthesis of guanine nucleotides from inosine monophosphate (IMP). - It is not directly involved in the catabolism of uric acid, and rasburicase has no known functional analogy to it. *Adenosine Deaminase* - **Adenosine deaminase** is an enzyme that catalyzes the deamination of adenosine to inosine. - Its deficiency is associated with a severe combined immunodeficiency (SCID), and it plays no direct role in uric acid metabolism related to rasburicase's action.
Explanation: ***Sodium bicarbonate*** - It readily reacts with **hydrochloric acid** in the stomach to produce water, carbon dioxide, and sodium chloride, effectively neutralizing stomach acid. - Its **rapid onset of action** makes it a popular choice for immediate relief from heartburn and indigestion. *Potassium chlorate* - This compound is primarily known for its use in **explosives** and as an **oxidizing agent**, not as an antacid. - Its ingestion can be **toxic**, causing methemoglobinemia and renal damage. *Potassium nitrate* - It is often used as a component in **toothpaste for sensitive teeth** to reduce pain, and in fertilizers, but not as an antacid. - It does not possess the necessary chemical properties to effectively neutralize stomach acid. *Nitroglycerin* - This compound is a potent **vasodilator** used primarily to treat angina (chest pain) by relaxing blood vessels. - It has **no antacid properties** and can cause significant side effects like hypotension and headaches.
Explanation: **All of the options** - **Botulinum toxin** is widely used in medicine to treat various conditions characterized by **muscle overactivity** or excessive glandular secretion. - Its mechanism of action involves blocking the release of **acetylcholine** at neuromuscular junctions or nerve endings, leading to muscle paralysis or reduced glandular activity. *Axillary hyperhidrosis* - **Botulinum toxin** is an effective treatment for **severe primary axillary hyperhidrosis**, which is characterized by excessive sweating in the armpits. - It works by blocking the release of **acetylcholine** from sympathetic nerves that stimulate sweat glands, thereby reducing sweat production. *Blepharospasm* - **Blepharospasm** is a focal dystonia characterized by **involuntary twitching or sustained contractions** of the muscles around the eyes, leading to forceful eyelid closure. - **Botulinum toxin injections** into the orbicularis oculi muscle weaken the excessive muscle contractions, providing symptomatic relief. *Cervical dystonia* - **Cervical dystonia** (also known as spasmodic torticollis) involves **involuntary contractions of neck and shoulder muscles**, causing the head to twist or turn abnormally. - **Botulinum toxin injections** into the affected neck muscles help relax them, reducing pain and abnormal posturing.
Explanation: ***It lacks central nervous system penetration.*** - **Glycopyrrolate** is a **quaternary ammonium compound** and is highly ionized, which prevents it from crossing the **blood-brain barrier**. - This characteristic significantly reduces the risk of **CNS side effects** such as sedation, confusion, or delirium, which are commonly associated with **atropine**. *It is a natural alkaloid* - **Atropine** is a **natural alkaloid** derived from plants like *Atropa belladonna*, whereas **glycopyrrolate** is a synthetic compound. - Being a natural alkaloid does not confer an advantage in terms of selective action or side effect profile. *Can be used in OPC poisoning* - Both **atropine** and **glycopyrrolate** can be used in the treatment of **organophosphate poisoning (OPC)** due to their anticholinergic properties. - However, **atropine** is generally preferred in acute OPC poisoning for its ability to reverse both peripheral and central muscarinic effects. *Is more potent* - While both are **antimuscarinic agents**, their potency can vary depending on the specific receptor subtype or clinical effect. - Glycopyrrolate is often cited for its potent **antisialagogue** (reducing saliva) effect, but atropine is more potent at blocking cardiac vagal effects.
Pharmacokinetics: Absorption and Distribution
Practice Questions
Pharmacokinetics: Metabolism and Excretion
Practice Questions
Pharmacodynamics and Receptor Theory
Practice Questions
Drug-Receptor Interactions and Dose-Response
Practice Questions
Pharmacogenetics and Personalized Medicine
Practice Questions
Adverse Drug Reactions and Toxicity
Practice Questions
Drug Interactions
Practice Questions
Drug Development and Regulation
Practice Questions
Pediatric and Geriatric Pharmacology
Practice Questions
Placental Transfer and Lactation
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free